Please note: The information displayed on this page might be outdated.
Anima Biotech: Anima Biotech is advancing its Translation Control Platform, the first and only platform for the discovery of small molecule drugs that control mRNA translation as a new strategy against many diseases. With novel biology that monitors the translation of proteins and proprietary cloud-based analysis software, we identify drug candidates that modulate a target protein’s production. We develop a pipeline across therapeutic areas and partner with Pharma for their targets including our $1B+ collaboration with Lilly for the discovery and development of translation inhibitors of several targets. Our approach was further validated with 5 granted patents, 14 peer reviewed publications and 17 scientific collaborations.
Sector/Industry:
/ Healthcare/Biotechnology
Characteristics:
Based in...
US - Middle Atlantic
Clinical Stage
Phase III, Phase l or ll, Pre-Clinical Stage
Disease Space
Anti-infectives, Antivirals, Fibrosis, Oncology, Rare Disease
Finance
Pre-Revenues
Listing
Private
Website:
Profiles:
Address:
75 Claremont Rd.
Ste 102
Bernardsville, NJ 07924
United States

Company Participants at European Biotech Investor Day 2020

  • Yochi Slonim, Co-founder & CEO, Board member